In next 15 years China is anticipated to join U.S., Europe, and Japan as a leader in biopharmaceutical sector.
Data revealed in Global Health Progress' (GHP) new fact sheet shows that China is projected to become one of the world's major biopharmaceutical players, along with the U.S., Europe, and Japan, in the next fifteen years. This projection is based on China's commitment to improving access to healthcar...
